Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1725 of 2026 entries
View as:

A Long Term Extension Study of WA19926 (NCT01007435) of Tocilizumab (RoActemra/Actemra) in Participants With Early, Moderate to Severe Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal
NCT ID: NCT01668966 Org: User:
Start: 12/09/13 End: 05/11/16 Due: 05/11/17

A Study Evaluating the Safety and Efficacy of Idasanutlin in Combination With Cytarabine and Daunorubicin in Patients Newly Diagnosed With Acute Myeloid Leukemia (AML) and the Safety and Efficacy of Idasanutlin in the Maintenance of First AML Complete Remission

Phase: N/A Priority: Normal
NCT ID: NCT03850535 Org: User:
Start: 03/25/19 End: 09/10/20 Due: 09/10/21

An Observational Study of First-Line Capecitabine Based Chemotherapy in Participants With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01696695 Org: User:
Start: 07/31/11 End: 12/31/14 Due: 12/31/15

An Observational Study of Xeloda (Capecitabine) Monotherapy in Patients With Colorectal Cancer (AXEL)

Phase: N/A Priority: Normal
NCT ID: NCT01276405 Org: User:
Start: 03/31/10 End: 10/31/15 Due: 10/31/16

A Study of Ritonavir-Boosted Danoprevir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients of Asian Origin With Chronic Hepatitis C Genotype 1 With or Without Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT01749150 Org: User:
Start: 04/30/13 End: 02/28/15 Due: 02/28/16

A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT01308684 Org: User:
Start: 05/31/11 End: 02/28/13 Due: 02/28/14

A Study to Investigate in Healthy Volunteers (Part 1) and in Patients With Type 2 Diabetes Mellitus (Part 2) the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of RO6799477

Phase: N/A Priority: Normal
NCT ID: NCT02164266 Org: User:
Start: 06/30/14 End: 12/31/14 Due: 12/31/15

A Study of RO5045337 [RG7112] in Patients With Hematologic Neoplasms.

Phase: N/A Priority: Normal
NCT ID: NCT00623870 Org: User:
Start: 05/31/08 End: 11/30/12 Due: 11/30/13

A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT04543617 Org: User:
Start: 09/28/20 End: 03/31/27 Due: 03/31/28

A Study to Evaluate Scales for Repetitive and Restricted Behaviors in Children, Adolescents, and Adults With Autism Spectrum Disorder (ASD)

Phase: N/A Priority: Normal
NCT ID: NCT03611075 Org: User:
Start: 08/13/18 End: 05/21/20 Due: 05/21/21

A Randomized, Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency Virus

Phase: N/A Priority: Normal
NCT ID: NCT00002095 Org: User:
Start: - End: - Due: -

Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria

Phase: N/A Priority: Normal
NCT ID: NCT03157635 Org: User:
Start: 11/14/16 End: 01/31/26 Due: 01/31/27

A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal
NCT ID: NCT00106535 Org: User:
Start: 01/31/05 End: 07/31/12 Due: 07/31/13

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06793215 Org: User:
Start: 12/01/25 End: 10/01/30 Due: 10/01/31

A Study of Risdiplam in Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy

Phase: N/A Priority: Normal
NCT ID: NCT03779334 Org: User:
Start: 08/07/19 End: 03/31/27 Due: 03/31/28

A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD)

Phase: N/A Priority: Normal
NCT ID: NCT05256134 Org: User:
Start: 04/19/22 End: 03/13/23 Due: 03/13/24

An Observational Study on The Impact of Insulin Resistance on Sustained Virological Response in Patients With Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)

Phase: N/A Priority: Normal
NCT ID: NCT01200225 Org: User:
Start: 02/28/10 End: 06/30/13 Due: 06/30/14

A Study to Assess the Hematopoyetic Response of Anemic Patients With Hematologic Malignancies Treated With Erythropoietin B

Phase: N/A Priority: Normal
NCT ID: NCT02608060 Org: User:
Start: 09/30/06 End: 10/31/07 Due: 10/31/08

The Safety and Effectiveness of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs

Phase: N/A Priority: Normal
NCT ID: NCT00002425 Org: User:
Start: - End: - Due: -

A Study Evaluating the Efficacy of Obinutuzumab and Bendamustine Treatment in Participants With Refractory or Relapsed Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02071225 Org: User:
Start: 04/09/14 End: 11/19/18 Due: 11/19/19

An Observational Study on Patients With Non-Squamous NSCLC Who Reached A Long PFS After Avastin (Bevacizumab)-Based First-Line Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01343914 Org: User:
Start: 06/30/11 End: 12/31/11 Due: 12/31/12

A Multiple Ascending Dose Study of RO4998452 in Patients With Type 2 Diabetes Mellitus.

Phase: N/A Priority: Normal
NCT ID: NCT00682097 Org: User:
Start: 05/31/08 End: 03/31/09 Due: 03/31/10

A Study to Investigate Atezolizumab Subcutaneous in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03735121 Org: User:
Start: 12/14/18 End: 11/11/24 Due: 11/11/25

A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03197935 Org: User:
Start: 07/24/17 End: 09/28/22 Due: 09/28/23

Study of Atezolizumab in Combination With Cabozantinib Versus Docetaxel in Patients With Metastatic Non-Small Cell Lung Cancer Previously Treated With an Anti-PD-L1/PD-1 Antibody and Platinum-Containing Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT04471428 Org: User:
Start: 10/01/20 End: 01/17/25 Due: 01/17/26